Entod Pharma Introduces Vitamin D3 Enriched Eye Drops for Dry Eyes

Entod Pharma Introduces Vitamin D3 Enriched Eye Drops for Dry Eyes

May 30, 2024

Mumbai-based Entod Pharmaceuticals announced the launch of novel Vitamin D3 enriched lubricating eye drops for individuals battling dry eyes.

These pioneering formulations mark a significant stride in ocular health, offering targeted relief for dry eye sufferers and presenting a first-of-its-kind offering in India.

The Benefits of Vitamin D3 Integration

Entod Pharmaceuticals has integrated Vitamin D3 into select lubricant eye drop brands, widely prescribed by eye care professionals for managing dry eyes.

Nikkhil K Masurkar, CEO of Entod Pharmaceuticals, highlighted the benefits of incorporating Vitamin D3 into dry eye treatment. He emphasized that this addition enhances ocular surface parameters, tear stability, tear osmolarity, and aids in corneal wound healing. Notably, Vitamin D3 enriched lubricating eye drops will be accessible exclusively through healthcare professional prescriptions.

Research indicates that inadequate Vitamin D3 levels can contribute to various eye conditions such as age-related macular degeneration, diabetic retinopathy, and dry eye syndrome. This innovative approach by Entod Pharmaceuticals offers hope for improved eye health and enhanced quality of life for individuals grappling with dry eyes.

About Dry Eyes

Dry eyes, a prevalent ocular condition, are characterized by a range of symptoms including discomfort, irritation, redness, and intermittent blurred vision. This condition occurs when tears fail to provide adequate lubrication for the eyes, leading to a disruption in the tear film. Various factors contribute to the development of dry eyes, including environmental influences such as dry climates or exposure to wind and smoke, as well as lifestyle factors like prolonged screen time, contact lens wear, and certain medications. Additionally, aging, hormonal changes, and systemic diseases such as diabetes can exacerbate dry eye symptoms.